Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy

References

• Thakar CV. Perioperative acute kidney injury. Adv Chronic Kidney Dis. 2013;20(1):67–75. doi: 10.1053/j.ackd.2012.10.003.
   PubMed Web of Science ®Google Scholar
• Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–448. doi: 10.1038/ki.2011.379.
   PubMed Web of Science ®Google Scholar
• Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40(2):256–260.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev. 2001;27(6):365–374. doi: 10.1053/ctrv.2001.0232.
   PubMed Web of Science ®Google Scholar
• Wajekar AS, Solanki SL, Patil VP. Postoperative complications and critical care management after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy: a systematic review of the literature. World J Crit Care Med. 2022;11(6):375–386. doi: 10.5492/wjccm.v11.i6.375.
   PubMedGoogle Scholar
• Foster JM, Sleightholm R, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847. doi: 10.1001/jamanetworkopen.2018.6847.
   PubMed Web of Science ®Google Scholar
• Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7(1):99–111. doi: 10.3978/j.issn.2078-6891.2015.100.
   PubMedGoogle Scholar
• Naffouje SA, Tulla KA, Chorley R, et al. Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg . 2018;35:163–168. doi: 10.1016/j.amsu.2018.09.036.
   PubMed Web of Science ®Google Scholar
• Liesenfeld LF, Wagner B, Hillebrecht HC, et al. HIPEC-Induced acute kidney injury: a retrospective clinical study and preclinical model. Ann Surg Oncol. 2022;29(1):139–151. doi: 10.1245/s10434-021-10376-5.
   PubMed Web of Science ®Google Scholar
• Sin EIL, Chia CS, Tan GHC, et al. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia. 2017;33(6):690–695. doi: 10.1080/02656736.2017.1293304.
   PubMed Web of Science ®Google Scholar
• Tang Y-Z, Zeng P, Liao Y, et al. Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis. BMJ Open. 2021;11(8):e047840. doi: 10.1136/bmjopen-2020-047840.
   PubMed Web of Science ®Google Scholar
• Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res. 2009;50 (Suppl):S29–S34. doi: 10.1194/jlr.R800042-JLR200.
   PubMedGoogle Scholar
• Xu N, Pang K, Qi S, et al. Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing radical mastectomy: a retrospective cohort analysis. BMC Anesthesiol. 2022;22(1):155. doi: 10.1186/s12871-022-01688-4.
   PubMed Web of Science ®Google Scholar
• Chang SC, Fingerhut A, Chen WT. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: propensity score-matched comparison between laparoscopy vs. open approaches. Surg Oncol. 2022;43:101766. doi: 10.1016/j.suronc.2022.101766.
   PubMed Web of Science ®Google Scholar
• Chang S-C, Seow-En I, Ke T-W, et al. Laparoscopic total pelvic peritonectomy for colorectal cancer pelvic carcinomatosis: a retrospective case series and photographic/videographic step-by-step guide. Surg Endosc. 2022;36(3):2178–2191. doi: 10.1007/s00464-021-08719-0.
   PubMed Web of Science ®Google Scholar
• Koole S, van Stein R, Sikorska K, et al. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Int J Gynecol Cancer. 2020;30(6):888–892. doi: 10.1136/ijgc-2020-001231.
   PubMed Web of Science ®Google Scholar
• Pinto A, Pocard M. Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: a systematic review of the literature. Pleura Peritoneum. 2019;4(2):20190006. doi: 10.1515/pp-2019-0006.
   PubMed Web of Science ®Google Scholar
• Van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240. doi: 10.1056/NEJMoa1708618.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Campanati L, Catena F, et al. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. J Gynecol Oncol. 2015;26(1):54–61. doi: 10.3802/jgo.2015.26.1.54.
   PubMed Web of Science ®Google Scholar
• Cornali T, Sammartino P, Kopanakis N, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer. Ann Surg Oncol. 2018;25(3):679–687. doi: 10.1245/s10434-017-6307-3.
   PubMed Web of Science ®Google Scholar
• Fliser D, Laville M, Covic A, et al. A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–4272. doi: 10.1093/ndt/gfs375.
   PubMed Web of Science ®Google Scholar
• O'Connor ME, Kirwan CJ, Pearse RM, et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med. 2016;42(4):521–530. doi: 10.1007/s00134-015-4157-7.
   PubMed Web of Science ®Google Scholar
• Cata JP, Zavala AM, Van Meter A, et al. Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. Int J Hyperthermia. 2018;34(5):538–544. doi: 10.1080/02656736.2017.1368096.
   PubMed Web of Science ®Google Scholar
• Chen KL, Shamavonian R, Karpes JB, et al. Acute kidney injury following hyperthermic intraperitoneal chemotherapy with cisplatin. Anticancer Res. 2021;41(3):1641–1646. doi: 10.21873/anticanres.14926.
   PubMed Web of Science ®Google Scholar
• Ceresoli M, Coccolini F, Ansaloni L. HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol. 2016;42(6):909–910. doi: 10.1016/j.ejso.2015.08.174.
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Chang H-Y, Lu C-H, et al. Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2020;37(1):1279–1286. doi: 10.1080/02656736.2020.1846793.
   PubMed Web of Science ®Google Scholar
• Canda AE, Sokmen S, Terzi C, et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20(4):1082–1087. doi: 10.1245/s10434-012-2853-x.
   PubMed Web of Science ®Google Scholar
• Hakeam HA, Breakiet M, Azzam A, et al. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail. 2014;36(10):1486–1491. doi: 10.3109/0886022X.2014.949758.
   PubMed Web of Science ®Google Scholar
• Ye J, Ren Y, Wei Z, et al. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: a retrospective cohort study. Surg Oncol. 2018;27(3):456–461. doi: 10.1016/j.suronc.2018.05.025.
   PubMed Web of Science ®Google Scholar
• Angeles MA, Quenet F, Vieille P, et al. Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis. Int J Gynecol Cancer. 2019;29(2):382–391. doi: 10.1136/ijgc-2018-000099.
   PubMed Web of Science ®Google Scholar
• McSweeney KR, Gadanec LK, Qaradakhi T, et al. Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers (Basel). 2021;13(7):1572. doi: 10.3390/cancers13071572.
   PubMed Web of Science ®Google Scholar
• Burns CV, Edwin SB, Szpunar S, et al. Cisplatin-induced nephrotoxicity in an outpatient setting. Pharmacotherapy. 2021;41(2):184–190. doi: 10.1002/phar.2500.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Azmi N, Fumagalli L, et al. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791). Eur J Surg Oncol. 2021;47(1):82–88. doi: 10.1016/j.ejso.2019.06.022.
   PubMed Web of Science ®Google Scholar
• Raspé C, Flöther L, Schneider R, et al. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2017;43(6):1013–1027. doi: 10.1016/j.ejso.2016.09.008.
   PubMed Web of Science ®Google Scholar
• Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011;9(1):169. doi: 10.1186/1477-7819-9-169.
   PubMedGoogle Scholar
• Iyigun M, Aykut G, Tosun M, et al. Perioperative risk factors of acute kidney injury after non-cardiac surgery: a multicenter, prospective, observational study in patients with low grade American society of anesthesiologists physical status. Am J Surg. 2019;218(3):457–461. doi: 10.1016/j.amjsurg.2019.01.031.
   PubMed Web of Science ®Google Scholar
• Arjona-Sánchez A, Cadenas-Febres A, Cabrera-Bermon J, et al. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869–876. doi: 10.1016/j.ejso.2015.12.016.
   PubMed Web of Science ®Google Scholar
• Mizota T, Yamamoto Y, Hamada M, et al. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth. 2017;119(6):1127–1134. doi: 10.1093/bja/aex255.
   PubMed Web of Science ®Google Scholar
• Myles PS, McIlroy DR, Bellomo R, et al. Importance of intraoperative oliguria during major abdominal surgery: findings of the restrictive versus liberal fluid therapy in major abdominal surgery trial. Br J Anaesth. 2019;122(6):726–733. doi: 10.1016/j.bja.2019.01.010.
   PubMed Web of Science ®Google Scholar
• Kirkby NS, Chan MV, Zaiss AK, et al. Systematic study of constitutive cyclooxygenase-2 expression: role of NF-κB and NFAT transcriptional pathways. Proc Natl Acad Sci U S A. 2016;113(2):434–439. doi: 10.1073/pnas.1517642113.
   PubMed Web of Science ®Google Scholar
• Schug S, Parsons B, Li C, et al. The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data. J Pain Res. 2017;volume10:2451–2459. doi: 10.2147/JPR.S136052.
   PubMed Web of Science ®Google Scholar
• Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol. 2001;281(1):F1–11. doi: 10.1152/ajprenal.2001.281.1.F1.
   PubMed Web of Science ®Google Scholar
• Puolakka PAE, Rintala S, Yli-Hankala A, et al. The effect of parecoxib on kidney function at laparoscopic hysterectomy. Ren Fail. 2009;31(4):284–289. doi: 10.1080/08860220902780051.
   PubMed Web of Science ®Google Scholar
• Hendrix RJ, Kassira JP, Lambert LA. Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with increased postoperative complications. Ann Surg Oncol. 2020;27(1):232–239. doi: 10.1245/s10434-019-07495-5.
   PubMed Web of Science ®Google Scholar